|
| 37937463 | Major Facilitator Superfamily Domain Containing 5 Inhibition Reduces Lipoprotein(a) Uptake and Calcification in Valvular Heart Disease. | Circulation | 2024 |
| 38065715 | Lipoprotein(a) levels and carotid intima-media thickness in children: A 20-year follow-up study. | J Clin Lipidol | 2024 |
| 37607461 | Lipoprotein(a) and the pooled cohort equations for ASCVD risk prediction: The Multi-Ethnic Study of Atherosclerosis. | Atherosclerosis | 2023 |
| 37487514 | Lipoprotein(a) and carotid intima-media thickness in children with familial hypercholesterolaemia in the Netherlands: a 20-year follow-up study. | Lancet Diabetes Endocrinol | 2023 |
| 37702041 | Lipoprotein(a) Testing Trends in a Large Academic Health System in the United States. | J Am Heart Assoc | 2023 |
| 34654019 | Clonal hematopoiesis driven by DNMT3A and TET2 mutations: role in monocyte and macrophage biology and atherosclerotic cardiovascular disease. | Curr Opin Hematol | 2022 |
| 35931086 | DNA methyltransferase 3 alpha and TET methylcytosine dioxygenase 2 restrain mitochondrial DNA-mediated interferon signaling in macrophages. | Immunity | 2022 |
| 35144769 | Trends in testing and prevalence of elevated Lp(a) among patients with aortic valve stenosis. | Atherosclerosis | 2022 |
| 34647487 | Lipoprotein(a): A Genetically Determined, Causal, and Prevalent Risk Factor for Atherosclerotic Cardiovascular Disease: A Scientific Statement From the American Heart Association. | Arterioscler Thromb Vasc Biol | 2022 |
| 34531030 | PCSK9 Inhibition and Oxidized Phospholipids. | J Am Coll Cardiol | 2021 |
| 33636163 | Novel method for quantification of lipoprotein(a)-cholesterol: implications for improving accuracy of LDL-C measurements. | J Lipid Res | 2021 |
| 31111151 | Statin therapy increases lipoprotein(a) levels. | Eur Heart J | 2020 |
| 32054669 | ApoCIII-Lp(a) complexes in conjunction with Lp(a)-OxPL predict rapid progression of aortic stenosis. | Heart | 2020 |
| 31893480 | Statins and increases in Lp(a): an inconvenient truth that needs attention. | Eur Heart J | 2020 |
| 32043488 | Ancient Remedy for a Modern Disease: Will Celastrol Become a Treatment for Aortic Valve Stenosis? | JACC Basic Transl Sci | 2020 |
| 33222611 | Low-Density Lipoprotein Cholesterol Corrected for Lipoprotein(a) Cholesterol, Risk Thresholds, and Cardiovascular Events. | J Am Heart Assoc | 2020 |
| 33027223 | The interconnection between lipoprotein(a), lipoprotein(a) cholesterol and true LDL-cholesterol in the diagnosis of familial hypercholesterolemia. | Curr Opin Lipidol | 2020 |
| 32641432 | Generation and characterization of LPA-KIV9, a murine monoclonal antibody binding a single site on apolipoprotein (a). | J Lipid Res | 2020 |
| 32387421 | Short-term regulation of hematopoiesis by lipoprotein(a) results in the production of pro-inflammatory monocytes. | Int J Cardiol | 2020 |
| 32160811 | Atherogenic Lipoprotein(a) Increases Vascular Glycolysis, Thereby Facilitating Inflammation and Leukocyte Extravasation. | Circ Res | 2020 |
| 30700108 | Lipoprotein(a) in Patients Undergoing Transcatheter Aortic Valve Replacement. | Angiology | 2019 |
| 29850765 | Reduction of myocardial ischaemia-reperfusion injury by inactivating oxidized phospholipids. | Cardiovasc Res | 2019 |
| 31551368 | Potent reduction of plasma lipoprotein (a) with an antisense oligonucleotide in human subjects does not affect ex vivo fibrinolysis. | J Lipid Res | 2019 |
| 29348025 | PET/MR Imaging of Malondialdehyde-Acetaldehyde Epitopes With a Human Antibody Detects Clinically Relevant Atherothrombosis. | J Am Coll Cardiol | 2018 |
| 30013121 | Publisher Correction: Oxidized phospholipids are proinflammatory and proatherogenic in hypercholesterolaemic mice. | Nature | 2018 |
| 29875409 | Oxidized phospholipids are proinflammatory and proatherogenic in hypercholesterolaemic mice. | Nature | 2018 |
| 30476957 | Association of Mild to Moderate Aortic Valve Stenosis Progression With Higher Lipoprotein(a) and Oxidized Phospholipid Levels: Secondary Analysis of a Randomized Clinical Trial. | JAMA Cardiol | 2018 |
| 29574075 | Relationship between "LDL-C", estimated true LDL-C, apolipoprotein B-100, and PCSK9 levels following lipoprotein(a) lowering with an antisense oligonucleotide. | J Clin Lipidol | 2018 |
| 28068801 | The Prevalence of Lipoprotein(a) Measurement and Degree of Elevation Among 2710 Patients With Calcific Aortic Valve Stenosis in an Academic Echocardiography Laboratory Setting. | Angiology | 2017 |
| 28360338 | Novel Lipoprotein(a) Catabolism Pathway via Apolipoprotein(a) Recycling: Adding the Plasminogen Receptor PlgR<sub>KT</sub> to the List. | Circ Res | 2017 |
| 29147686 | Lipoprotein(a) Associated Molecules are Prominent Components in Plasma and Valve Leaflets in Calcific Aortic Valve Stenosis. | JACC Basic Transl Sci | 2017 |
| 26780907 | Experimental Animal Models Evaluating the Causal Role of Lipoprotein(a) in Atherosclerosis and Aortic Stenosis. | Cardiovasc Drugs Ther | 2016 |
| 27919356 | Lipoprotein(a)-cholesterol levels estimated by vertical auto profile correlate poorly with Lp(a) mass in hyperlipidemic subjects: Implications for clinical practice interpretation of Lp(a)-mediated risk. | J Clin Lipidol | 2016 |
| 27206947 | Effect of therapeutic interventions on oxidized phospholipids on apolipoprotein B100 and lipoprotein(a). | J Clin Lipidol | 2016 |
| 27205885 | Lipoprotein(a) and oxidized phospholipids in calcific aortic valve stenosis. | Curr Opin Cardiol | 2016 |
| 27121620 | PCSK9 Association With Lipoprotein(a). | Circ Res | 2016 |
| 27118508 | The role of lipoprotein(a) in progression of renal disease: Causality or reverse causality? | J Diabetes Complications | 2016 |
| 27496857 | Oxidized Phospholipids on Lipoprotein(a) Elicit Arterial Wall Inflammation and an Inflammatory Monocyte Response in Humans. | Circulation | 2016 |
| 26014961 | HDL-C, ABCA1-mediated cholesterol efflux, and lipoprotein(a): insights into a potential novel physiologic role of lipoprotein(a). | J Lipid Res | 2015 |
| 26361154 | Oxidized Phospholipids, Lipoprotein(a), and Progression of Calcific Aortic Valve Stenosis. | J Am Coll Cardiol | 2015 |
| 25943842 | 'LDL-C'â¿¿=â¿¿LDL-Câ¿¿+â¿¿Lp(a)-C: implications of achieved ultra-low LDL-C levels in the proprotein convertase subtilisin/kexin type 9 era of potent LDL-C lowering. | Curr Opin Lipidol | 2015 |
| 25297940 | Imaging of oxidation-specific epitopes with targeted nanoparticles to detect high-risk atherosclerotic lesions: progress and future directions. | J Cardiovasc Transl Res | 2014 |
| 21191108 | Sphingomyelin synthase 2 (SMS2) deficiency attenuates LPS-induced lung injury. | Am J Physiol Lung Cell Mol Physiol | 2011 |
| 22168400 | Subcellular targeting domains of sphingomyelin synthase 1 and 2. | Nutr Metab (Lond) | 2011 |
| 21365262 | Role of phospholipid transfer protein in high-density lipoprotein- mediated reverse cholesterol transport. | Curr Atheroscler Rep | 2011 |
| 20543142 | Diet-induced lipid accumulation in phospholipid transfer protein-deficient mice: its atherogenicity and potential mechanism. | J Lipid Res | 2010 |
| 18694848 | The domain responsible for sphingomyelin synthase (SMS) activity. | Biochim Biophys Acta | 2008 |
| 17641249 | Phospholipid transfer protein-deficient mice absorb less cholesterol. | Arterioscler Thromb Vasc Biol | 2007 |